An ethical framework for the creation, governance and evaluation of accelerated access programs

Area of Science:

• Health Policy
• Medical Ethics
• Pharmaceutical Regulation

Background:

• Increasing international demand for faster patient access to new medicines.
• Need for quicker access, especially for rare diseases, life-threatening conditions, and public health emergencies.
• Traditional evidence requirements for safety, efficacy, and cost-effectiveness are being challenged.

Purpose of the Study:

• To analyze the ethical and political implications of accelerated access programs.
• To develop a conceptual framework for understanding different types of accelerated access.
• To inform ethically and politically sound policy-making regarding expedited drug approval.

Main Methods:

• Conceptual analysis of accelerated access initiatives.
• Identification of common and specific ethical issues across different programs.
• Development of a framework for policy evaluation.

Main Results:

• Accelerated access programs present complex socio-political, epistemic, and moral challenges.
• Ethical issues vary depending on the specific type of accelerated access program.
• A conceptual framework can distinguish ethically relevant similarities and differences.

Conclusions:

• Understanding the nuances of accelerated access programs is crucial for responsible policy development.
• Ethical frameworks are needed to navigate the trade-offs between speed of access and evidence requirements.
• Informed policy-making requires careful consideration of the ethical landscape of expedited drug approval.